The lipid storage myopathies: morphological and clinical aspects

D. Peluchetti, F. Cornelio, M. Mora, S. Daniel

Research output: Contribution to journalArticle

Abstract

Recently the possible existence of a specific defect in muscle lipid metabolism has been considered and a correlation between disturbance of lipid utilization and myopathic impairment has been proposed. A syndrome of subacute proximal myopathy and abnormal lipid accumulation in Type I muscle fibers was reported by Bradley et al. (1969). They defined this condition as 'Lipid Storage Myopathy' (LSM) and speculated that the lipid accumulation was due to an impaired mitochondrial oxidation of free fatty acids (FFA). An impairment of long chain fatty acid (LCFA) utilization was subsequently demonstrated by Engel et al. (1970). From a morphological point of view muscle biopsies of all cases of Lipid Storage Myopathy so far reported present a quite uniform picture. Histological specimens always reveal a vacuolar myopathy with some fibers more affected than others. Histoenzymatic techniques indicate that the abnormal spaces in the muscle fibers are filled with neutral fat. Histochemically the affected fibers are generally Type I and in some cases the Type I fibers appear to be atrophic. The clinical picture of the Lipid Storage Myopathies fail to appear as a uniform and distinct entity. Difference can be recognized in the age of onset, in progression of the disease and the involvement of the skeletal muscles and other organs. Moreover, one can tentatively classify the cases so far reported into 3 main categories.

Original languageEnglish
Pages (from-to)93-99
Number of pages7
JournalBiochemistry and Experimental Biology
Volume13
Issue number1
Publication statusPublished - 1977

Fingerprint

Lipids
Muscles
Slow-Twitch Muscle Fibers
Muscular Diseases
Lipid Metabolism
Age of Onset
Nonesterified Fatty Acids
Disease Progression
Skeletal Muscle
Fatty Acids
Fats
Biopsy
Myopathy with Abnormal Lipid Metabolism
Vacuolar myopathy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The lipid storage myopathies : morphological and clinical aspects. / Peluchetti, D.; Cornelio, F.; Mora, M.; Daniel, S.

In: Biochemistry and Experimental Biology, Vol. 13, No. 1, 1977, p. 93-99.

Research output: Contribution to journalArticle

Peluchetti, D, Cornelio, F, Mora, M & Daniel, S 1977, 'The lipid storage myopathies: morphological and clinical aspects', Biochemistry and Experimental Biology, vol. 13, no. 1, pp. 93-99.
Peluchetti, D. ; Cornelio, F. ; Mora, M. ; Daniel, S. / The lipid storage myopathies : morphological and clinical aspects. In: Biochemistry and Experimental Biology. 1977 ; Vol. 13, No. 1. pp. 93-99.
@article{21fb214b0d414c3dae5a41a315124904,
title = "The lipid storage myopathies: morphological and clinical aspects",
abstract = "Recently the possible existence of a specific defect in muscle lipid metabolism has been considered and a correlation between disturbance of lipid utilization and myopathic impairment has been proposed. A syndrome of subacute proximal myopathy and abnormal lipid accumulation in Type I muscle fibers was reported by Bradley et al. (1969). They defined this condition as 'Lipid Storage Myopathy' (LSM) and speculated that the lipid accumulation was due to an impaired mitochondrial oxidation of free fatty acids (FFA). An impairment of long chain fatty acid (LCFA) utilization was subsequently demonstrated by Engel et al. (1970). From a morphological point of view muscle biopsies of all cases of Lipid Storage Myopathy so far reported present a quite uniform picture. Histological specimens always reveal a vacuolar myopathy with some fibers more affected than others. Histoenzymatic techniques indicate that the abnormal spaces in the muscle fibers are filled with neutral fat. Histochemically the affected fibers are generally Type I and in some cases the Type I fibers appear to be atrophic. The clinical picture of the Lipid Storage Myopathies fail to appear as a uniform and distinct entity. Difference can be recognized in the age of onset, in progression of the disease and the involvement of the skeletal muscles and other organs. Moreover, one can tentatively classify the cases so far reported into 3 main categories.",
author = "D. Peluchetti and F. Cornelio and M. Mora and S. Daniel",
year = "1977",
language = "English",
volume = "13",
pages = "93--99",
journal = "Biochemistry and Experimental Biology",
issn = "0366-0060",
number = "1",

}

TY - JOUR

T1 - The lipid storage myopathies

T2 - morphological and clinical aspects

AU - Peluchetti, D.

AU - Cornelio, F.

AU - Mora, M.

AU - Daniel, S.

PY - 1977

Y1 - 1977

N2 - Recently the possible existence of a specific defect in muscle lipid metabolism has been considered and a correlation between disturbance of lipid utilization and myopathic impairment has been proposed. A syndrome of subacute proximal myopathy and abnormal lipid accumulation in Type I muscle fibers was reported by Bradley et al. (1969). They defined this condition as 'Lipid Storage Myopathy' (LSM) and speculated that the lipid accumulation was due to an impaired mitochondrial oxidation of free fatty acids (FFA). An impairment of long chain fatty acid (LCFA) utilization was subsequently demonstrated by Engel et al. (1970). From a morphological point of view muscle biopsies of all cases of Lipid Storage Myopathy so far reported present a quite uniform picture. Histological specimens always reveal a vacuolar myopathy with some fibers more affected than others. Histoenzymatic techniques indicate that the abnormal spaces in the muscle fibers are filled with neutral fat. Histochemically the affected fibers are generally Type I and in some cases the Type I fibers appear to be atrophic. The clinical picture of the Lipid Storage Myopathies fail to appear as a uniform and distinct entity. Difference can be recognized in the age of onset, in progression of the disease and the involvement of the skeletal muscles and other organs. Moreover, one can tentatively classify the cases so far reported into 3 main categories.

AB - Recently the possible existence of a specific defect in muscle lipid metabolism has been considered and a correlation between disturbance of lipid utilization and myopathic impairment has been proposed. A syndrome of subacute proximal myopathy and abnormal lipid accumulation in Type I muscle fibers was reported by Bradley et al. (1969). They defined this condition as 'Lipid Storage Myopathy' (LSM) and speculated that the lipid accumulation was due to an impaired mitochondrial oxidation of free fatty acids (FFA). An impairment of long chain fatty acid (LCFA) utilization was subsequently demonstrated by Engel et al. (1970). From a morphological point of view muscle biopsies of all cases of Lipid Storage Myopathy so far reported present a quite uniform picture. Histological specimens always reveal a vacuolar myopathy with some fibers more affected than others. Histoenzymatic techniques indicate that the abnormal spaces in the muscle fibers are filled with neutral fat. Histochemically the affected fibers are generally Type I and in some cases the Type I fibers appear to be atrophic. The clinical picture of the Lipid Storage Myopathies fail to appear as a uniform and distinct entity. Difference can be recognized in the age of onset, in progression of the disease and the involvement of the skeletal muscles and other organs. Moreover, one can tentatively classify the cases so far reported into 3 main categories.

UR - http://www.scopus.com/inward/record.url?scp=0017591085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017591085&partnerID=8YFLogxK

M3 - Article

C2 - 614048

AN - SCOPUS:0017591085

VL - 13

SP - 93

EP - 99

JO - Biochemistry and Experimental Biology

JF - Biochemistry and Experimental Biology

SN - 0366-0060

IS - 1

ER -